个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共10条记录  
  • Lurasidone hydrochloride
    [作者:Cole, P; Serradell, N; Rosa, E; Bolos, J,期刊:Drugs of the Future, 页码:316-322 , 文章类型: Article,,卷期:2008年33-4]
  • Despite important innovations in the pharmacotherapy of schizophrenia in the last few decades, most notably the introduction of a number of dual-acting dopamine D2/5-HT2A antagonists, there remains a need for more eff...

  • MGCD-0103
    [作者:Kell, J,期刊:Drugs of the Future, 页码:323-327 , 文章类型: Article,,卷期:2008年33-4]
  • MGCD-0103 is an orally active isoform-selective histone deacetylase (HDAC) inhibitor under development by MethylGene in cooperation with Pharmion. Histone acetylation represents an attractive target in cancer therapy ...

  • mGluR(5) positive allosteric modulators
    [作者:Chen, YL; Conn, PJ,期刊:Drugs of the Future, 页码:355-360 , 文章类型: Review,,卷期:2008年33-4]
  • The mGluR(5) subtype of metabotropic glutamate receptor (mGluR) plays an important role in the modulation of neuronal excitability and synaptic transmission in a number of brain circuits. These slow synaptic responses...

  • Apixaban
    [作者:Bates, SM; Weitz, JI,期刊:Drugs of the Future, 页码:293-301 , 文章类型: Article,,卷期:2008年33-4]
  • Currently available anticoagulants include heparin, low-molecular-weight heparin, fondaparinux and warfarin. Despite advances, currently available agents have limitations that have provided the impetus for the develop...

  • Ceftaroline fosamil
    [作者:Wang, Y; Mealy, N,期刊:Drugs of the Future, 页码:302-309 , 文章类型: Article,,卷期:2008年33-4]
  • Ceftaroline fosamil (PPI-0903, TAK-599) is a novel N-phosphono prodrug of PPI-0903M (ceftaroline, T-91825), a broad-spectrum cephalosporin antibiotic with potent activity against methicillin-resistant Staphylococcus a...

  • Elesclomol
    [作者:Revill, P; Mealy, N; Serradell, N; Rosa, E; Bolos, J,期刊:Drugs of the Future, 页码:310-315 , 文章类型: Article,,卷期:2008年33-4]
  • Elesclomol (STA-4783) is a small molecule that induces apoptosis via the mitochondrial apoptotic pathway in cancer cells by increasing oxidative stress, while having little or no effect on normal cells. The agent acts...